...
首页> 外文期刊>The Open Virology Journal >Interaction of Adenovirus E1A with the HHV8 Promoter of Latent Genes: E1A Proteins are Able to Activate the HHV-8 LANAp in MV3 Reporter Cells
【24h】

Interaction of Adenovirus E1A with the HHV8 Promoter of Latent Genes: E1A Proteins are Able to Activate the HHV-8 LANAp in MV3 Reporter Cells

机译:腺病毒E1A与潜在基因HHV8启动子的相互作用:E1A蛋白能够激活MV3报告细胞中的HHV-8 LANAp

获取原文
           

摘要

Human herpesvirus 8 (HHV-8) is associated with Kaposi’s sarcoma, body cavity-based lymphoma, and Castleman’s disease. Adenoviral (Ad) E1A proteins regulate the activity of cellular and viral promoters/enhancers and transcription factors and can suppress tumorigenicity of human cancers. As (i) HHV-8 and Ad may co-exist in immunocompromised patients and (ii) E1A might be considered as therapeutic transgene for HHV-8-associated neoplasms we investigated whether the promoter of the latency-associated nuclear antigen (LANAp) controlling expression of vCyclin, vFLIP, and LANA proteins required for latent type infection is regulated by E1A. Transfection experiments in MV3 melanoma cells revealed activation of the LANAp by Ad5 E1A constructs containing an intact N terminus (aa 1-119). In particular, an Ad12 E1A mutant, Spm2, lacking six consecutive alanine residues in the “spacer” region activated the HHV-8 promoter about 15-fold compared to vector controls. In summary, we report the activation of the LANAp by E1A as a novel interaction of E1A with a viral promoter. These data may have relevance for the management of viral infections in immunocompromised patients. A role for E1A as a therapeutic in this context remains to be defined.
机译:人类疱疹病毒8(HHV-8)与卡波西氏肉瘤,基于体腔的淋巴瘤和Castleman病有关。腺病毒(Ad)E1A蛋白调节细胞和病毒启动子/增强子和转录因子的活性,并可以抑制人类癌症的致癌性。由于(i)HHV-8和Ad可能共存于免疫功能低下的患者中,并且(ii)E1A被认为是HHV-8相关肿瘤的治疗性转基因,因此我们调查了潜伏期相关核抗原(LANAp)的启动子是否受到控制潜在型感染所需的vCyclin,vFLIP和LANA蛋白的表达受E1A调控。在MV3黑色素瘤细胞中进行的转染实验表明,包含完整N末端(aa 1-119)的Ad5 E1A构建体激活了LANAp。特别是,与载体对照相比,在“间隔区”中缺少六个连续的丙氨酸残基的Ad12 E1A突变体Spm2激活了HHV-8启动子约15倍。总之,我们报道了E1A对LANAp的激活,这是E1A与病毒启动子的新型相互作用。这些数据可能与免疫功能低下患者的病毒感染的管理有关。在这种情况下,E1A作为治疗剂的作用尚待确定。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号